Royce & Associates LP lifted its stake in shares of Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI – Free Report) by 25.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 988,517 shares of the company’s stock after purchasing an additional 199,477 shares during the period. Royce & Associates LP owned approximately 1.03% of Lumexa Imaging worth $10,132,000 at the end of the most recent reporting period.
Several other hedge funds have also modified their holdings of the stock. State of Alaska Department of Revenue acquired a new stake in shares of Lumexa Imaging in the third quarter valued at approximately $46,000. PNC Financial Services Group Inc. acquired a new position in Lumexa Imaging during the 1st quarter worth $63,000. State of Wyoming acquired a new position in Lumexa Imaging during the 1st quarter worth $91,000. AXQ Capital LP bought a new position in Lumexa Imaging in the 2nd quarter valued at $128,000. Finally, Bank of America Corp DE bought a new position in Lumexa Imaging in the 2nd quarter valued at $200,000.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on the company. KeyCorp assumed coverage on Lumexa Imaging in a research report on Thursday, September 24th. They set an “overweight” rating and a $18.00 target price for the company. Barclays upped their price target on Lumexa Imaging from $13.00 to $17.00 and gave the company an “overweight” rating in a research note on Tuesday. Raymond James Financial set a $19.00 price target on Lumexa Imaging and gave the company a “strong-buy” rating in a report on Wednesday, November 11th. UBS Group reiterated a “strong-buy” rating on shares of Lumexa Imaging in a research report on Wednesday, November 11th. Finally, Wall Street Zen raised Lumexa Imaging from a “hold” rating to a “buy” rating in a report on Saturday, October 3rd. Two equities research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $17.60.
Lumexa Imaging Stock Down 1.1%
Shares of LMRI stock opened at $14.63 on Wednesday. The firm’s 50 day moving average price is $11.57 and its two-hundred day moving average price is $11.10. The company has a quick ratio of 1.52, a current ratio of 1.52 and a debt-to-equity ratio of 1.36. Lumexa Imaging Holdings, Inc. has a 52-week low of $6.45 and a 52-week high of $19.45.
Lumexa Imaging (NASDAQ:LMRI – Get Free Report) last issued its earnings results on Tuesday, November 10th. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.07 by $0.19. The company had revenue of $271.97 million during the quarter. Lumexa Imaging had a negative net margin of 1.96% and a negative return on equity of 2.89%. As a group, equities analysts forecast that Lumexa Imaging Holdings, Inc. will post 0.27 EPS for the current year.
Lumexa Imaging Profile
Lumexa Imaging operates outpatient diagnostic imaging centers that provide radiology services to patients, referring physicians and healthcare providers. Its services include imaging used to help diagnose and monitor a range of medical conditions. The company offers diagnostic procedures such as MRI, CT, PET/CT, mammography, ultrasound and X-ray through its imaging centers and affiliated radiology practices. Lumexa serves communities across the United States, providing an outpatient option for medical imaging outside of a hospital setting.
Read More
- Five stocks we like better than Lumexa Imaging
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for Lumexa Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lumexa Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
